🔎 Trials Near Me

Home › Dermatomyositis › North Carolina

Pag-aaral pangklinika para sa Dermatomyositis sa North Carolina

8 pag-aaral para sa Dermatomyositis ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Environmental Risk Factors for the Anti-synthetase Syndrome

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT01276470

Adult and Juvenile Myositis

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT00017914

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
Nagre-recruitPhase 2/3
Edad 6 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Atrium Health Rheumatology-Southpark, Charlotte
  • Duke University Medical Center, Durham
Nagre-recruitPhase 1
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 10, 2026 · NCT07085104

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

  • Universtity of North Carolina at Chapel Hill, Chapel Hill
Nagre-recruitPhase 1
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06371417

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Duke University, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT07115745

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.